Thrivent Financial for Lutherans’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q1 | – | Sell |
-45,976
| Closed | -$184K | – | 2354 |
|
2019
Q4 | $184K | Buy |
45,976
+516
| +1% | +$2.07K | ﹤0.01% | 2175 |
|
2019
Q3 | $223K | Buy |
45,460
+1,055
| +2% | +$5.18K | ﹤0.01% | 2111 |
|
2019
Q2 | $270K | Buy |
44,405
+1,198
| +3% | +$7.28K | ﹤0.01% | 2055 |
|
2019
Q1 | $251K | Buy |
43,207
+3,783
| +10% | +$22K | ﹤0.01% | 2058 |
|
2018
Q4 | $531K | Buy |
39,424
+867
| +2% | +$11.7K | ﹤0.01% | 1525 |
|
2018
Q3 | $748K | Buy |
38,557
+5,501
| +17% | +$107K | ﹤0.01% | 1465 |
|
2018
Q2 | $845K | Buy |
33,056
+629
| +2% | +$16.1K | ﹤0.01% | 1367 |
|
2018
Q1 | $653K | Buy |
32,427
+2,589
| +9% | +$52.1K | ﹤0.01% | 1487 |
|
2017
Q4 | $599K | Buy |
29,838
+588
| +2% | +$11.8K | ﹤0.01% | 1574 |
|
2017
Q3 | $606K | Buy |
29,250
+2,980
| +11% | +$61.7K | ﹤0.01% | 1465 |
|
2017
Q2 | $389K | Sell |
26,270
-284,310
| -92% | -$4.21M | ﹤0.01% | 1646 |
|
2017
Q1 | $4.95M | Buy |
310,580
+46,690
| +18% | +$745K | 0.02% | 585 |
|
2016
Q4 | $3.33M | Buy |
263,890
+241,760
| +1,092% | +$3.05M | 0.01% | 714 |
|
2016
Q3 | $620K | Buy |
22,130
+4,610
| +26% | +$129K | ﹤0.01% | 1361 |
|
2016
Q2 | $613K | Buy |
17,520
+780
| +5% | +$27.3K | ﹤0.01% | 1324 |
|
2016
Q1 | $459K | Buy |
+16,740
| New | +$459K | ﹤0.01% | 1405 |
|